Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Depreciation and Depletion (2016 - 2020)

Historic Depreciation and Depletion for Macrogenics (MGNX) over the last 7 years, with Q4 2020 value amounting to $2.9 million.

  • Macrogenics' Depreciation and Depletion fell 421.29% to $2.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $12.0 million, marking a year-over-year increase of 2832.73%. This contributed to the annual value of $7.5 million for FY2024, which is 2187.5% down from last year.
  • Latest data reveals that Macrogenics reported Depreciation and Depletion of $2.9 million as of Q4 2020, which was down 421.29% from $3.0 million recorded in Q3 2020.
  • In the past 5 years, Macrogenics' Depreciation and Depletion ranged from a high of $3.1 million in Q4 2019 and a low of $1.2 million during Q4 2016
  • For the 3-year period, Macrogenics' Depreciation and Depletion averaged around $2.4 million, with its median value being $2.5 million (2016).
  • Data for Macrogenics' Depreciation and Depletion shows a peak YoY increase of 32474.44% (in 2016) and a maximum YoY decrease of 2374.1% (in 2016) over the last 5 years.
  • Quarter analysis of 3 years shows Macrogenics' Depreciation and Depletion stood at $1.2 million in 2016, then soared by 162.61% to $3.1 million in 2019, then fell by 4.21% to $2.9 million in 2020.
  • Its last three reported values are $2.9 million in Q4 2020, $3.0 million for Q3 2020, and $3.1 million during Q4 2019.